NASDAQ:NVCR | Market Exclusive

Home Tags NASDAQ:NVCR

Analyst Upgrades – NASDAQ:NVCR – NovoCure (NASDAQ:NVCR) Stock Gets Upgraded By...

ME Staff - April 19, 2018 0

Analyst Activity – Mizuho Reiterates Buy on NASDAQ:NVCR – NovoCure (NASDAQ:NVCR)

ME Staff - April 18, 2018 0

Analyst Activity – Deutsche Bank Lowers Its Price Target On Novocure...

ME Staff - February 23, 2018 0

Novocure (NASDAQ:NVCR) reported earnings of ($0.12) per share beating Walls Streets...

ME Staff - February 22, 2018 0

Novocure Ltd (NASDAQ:NVCR) Announces Optune Will Be Available In 600 Locations...

- July 13, 2017 0

NovoCure Limited (NASDAQ:NVCR) Files An 8-K Results of Operations and Financial...

ME Staff 8-k - April 27, 2017 0

NovoCure Limited (NASDAQ:NVCR) Files An 8-K Entry into a Material Definitive...

ME Staff 8-k - December 30, 2016 0

Insider Trading Activity NovoCure Ltd. (NASDAQ:NVCR) – COO Sold 27,500 shares...

ME Staff - December 23, 2016 0

Insider Trading Activity NovoCure Ltd. (NASDAQ:NVCR) – COO Sold 27,500 shares...

ME Staff - December 23, 2016 0

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

October 13, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 22, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NASDAQ:NVCR

Analyst Upgrades – NASDAQ:NVCR – NovoCure (NASDAQ:NVCR) Stock Gets Upgraded By...

Analyst Activity – Mizuho Reiterates Buy on NASDAQ:NVCR – NovoCure (NASDAQ:NVCR)

Analyst Activity – Deutsche Bank Lowers Its Price Target On Novocure...

Novocure (NASDAQ:NVCR) reported earnings of ($0.12) per share beating Walls Streets...

Novocure Ltd (NASDAQ:NVCR) Announces Optune Will Be Available In 600 Locations...

NovoCure Limited (NASDAQ:NVCR) Files An 8-K Results of Operations and Financial...

NovoCure Limited (NASDAQ:NVCR) Files An 8-K Entry into a Material Definitive...

Insider Trading Activity NovoCure Ltd. (NASDAQ:NVCR) – COO Sold 27,500 shares...

Insider Trading Activity NovoCure Ltd. (NASDAQ:NVCR) – COO Sold 27,500 shares...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY